Item Type | Name |
Concept
|
Brain Injuries, Traumatic
|
Concept
|
Amygdala
|
Concept
|
Adenylyl Cyclases
|
Concept
|
Analgesics, Opioid
|
Concept
|
Adrenergic alpha-Antagonists
|
Concept
|
Adrenergic beta-Agonists
|
Concept
|
Adrenergic beta-Antagonists
|
Concept
|
Age Factors
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Calcium
|
Concept
|
Carbachol
|
Concept
|
Amino Acid Sequence
|
Concept
|
Cyclic AMP
|
Concept
|
Body Weight
|
Concept
|
Base Sequence
|
Concept
|
Catecholamines
|
Concept
|
Brain Concussion
|
Concept
|
Brain Neoplasms
|
Concept
|
Cattle
|
Concept
|
Benzamides
|
Concept
|
Cell Line
|
Concept
|
Cell Membrane
|
Concept
|
Cell Nucleus
|
Concept
|
Bufo marinus
|
Concept
|
Chronic Disease
|
Concept
|
Corpus Striatum
|
Concept
|
Cycloheptanes
|
Concept
|
Cycloheximide
|
Concept
|
Enkephalin, Leucine
|
Concept
|
Enkephalins
|
Concept
|
Feeding Behavior
|
Concept
|
Epinephrine
|
Concept
|
Eating
|
Concept
|
Hippocampus
|
Concept
|
Cricetinae
|
Concept
|
Gastrointestinal Motility
|
Concept
|
Hot Temperature
|
Concept
|
Glial Fibrillary Acidic Protein
|
Concept
|
Goldfish
|
Concept
|
Magnesium
|
Concept
|
Manganese
|
Concept
|
Injections, Intraventricular
|
Concept
|
Nitroprusside
|
Concept
|
Norepinephrine
|
Concept
|
Naloxone
|
Concept
|
Naltrexone
|
Concept
|
Narcotics
|
Concept
|
Isoproterenol
|
Concept
|
Microinjections
|
Concept
|
Molecular Sequence Data
|
Concept
|
Morbidity
|
Concept
|
Morphine
|
Concept
|
Morphine Derivatives
|
Concept
|
Pituitary Neoplasms
|
Concept
|
Reticulocytes
|
Concept
|
Pentazocine
|
Concept
|
Periaqueductal Gray
|
Concept
|
Synapses
|
Concept
|
Synaptic Vesicles
|
Concept
|
Synaptosomes
|
Concept
|
Radioligand Assay
|
Concept
|
Tetradecanoylphorbol Acetate
|
Concept
|
Tretinoin
|
Concept
|
Thalamus
|
Concept
|
Receptors, GABA-A
|
Concept
|
Blotting, Western
|
Concept
|
Neuroimmunomodulation
|
Concept
|
Subcellular Fractions
|
Concept
|
Oligonucleotide Probes
|
Concept
|
Sequence Homology, Amino Acid
|
Concept
|
Receptors, Opioid, delta
|
Concept
|
Enkephalin, Leucine-2-Alanine
|
Concept
|
NF-kappa B
|
Concept
|
Fluorescent Antibody Technique, Indirect
|
Concept
|
CHO Cells
|
Concept
|
GABA Antagonists
|
Concept
|
Neurites
|
Concept
|
GTP-Binding Proteins
|
Concept
|
Oligodeoxyribonucleotides, Antisense
|
Concept
|
DNA, Complementary
|
Concept
|
Receptors, Adrenergic, alpha-2
|
Concept
|
Receptors, Adrenergic, beta-2
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
Concept
|
Pseudopodia
|
Concept
|
beta-Adrenergic Receptor Kinases
|
Concept
|
G-Protein-Coupled Receptor Kinase 2
|
Concept
|
G-Protein-Coupled Receptor Kinase 3
|
Concept
|
Tritium
|
Concept
|
Trypsin
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Ultraviolet Rays
|
Concept
|
Gene Expression
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Presynaptic Terminals
|
Concept
|
History, 20th Century
|
Concept
|
History, 21st Century
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
Concept
|
R-SNARE Proteins
|
Concept
|
Qa-SNARE Proteins
|
Concept
|
Octamer Transcription Factor-2
|
Concept
|
Synaptosomal-Associated Protein 25
|
Concept
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
|
Concept
|
Enkephalin, D-Penicillamine (2,5)-
|
Concept
|
Cell Line, Tumor
|
Concept
|
Adrenergic alpha-2 Receptor Agonists
|
Concept
|
Adrenergic beta-2 Receptor Agonists
|
Concept
|
Adrenergic beta-2 Receptor Antagonists
|
Concept
|
Benzophenanthridines
|
Concept
|
Cells, Cultured
|
Concept
|
Hypoxia, Brain
|
Concept
|
Cerebral Cortex
|
Concept
|
Dietary Carbohydrates
|
Concept
|
Diprenorphine
|
Concept
|
Disease Models, Animal
|
Concept
|
Dopamine
|
Concept
|
Flavonoids
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Colforsin
|
Concept
|
gamma-Aminobutyric Acid
|
Concept
|
Hypothalamus
|
Concept
|
Immunohistochemistry
|
Concept
|
Membrane Potentials
|
Academic Article
|
Orphanin FQ/nociceptin activates nuclear factor kappa B.
|
Academic Article
|
Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions.
|
Academic Article
|
Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
|
Academic Article
|
Blast Overpressure Waves Induce Transient Anxiety and Regional Changes in Cerebral Glucose Metabolism and Delayed Hyperarousal in Rats.
|
Academic Article
|
3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line.
|
Academic Article
|
Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells.
|
Academic Article
|
Vesicle-associated membrane protein isoforms in the tiger salamander retina.
|
Academic Article
|
Desensitization of alpha 2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by beta 2-adrenoceptor-dependent GRK3 up-regulation.
|
Academic Article
|
Simultaneous alpha2B- and beta2-adrenoceptor activation sensitizes the alpha2B-adrenoceptor for agonist-induced down-regulation.
|
Academic Article
|
Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor.
|
Academic Article
|
Sex Differences in Nociceptin/Orphanin FQ Peptide Receptor-Mediated Pain and Anxiety Symptoms in a Preclinical Model of Post-traumatic Stress Disorder.
|
Academic Article
|
Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder.
|
Academic Article
|
Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro.
|
Academic Article
|
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
|
Academic Article
|
Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats.
|
Academic Article
|
Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.
|
Academic Article
|
Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment.
|
Academic Article
|
Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
|
Academic Article
|
Assessing opioid regulation of adenylyl cyclase activity in intact cells.
|
Academic Article
|
Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
|
Academic Article
|
Methylnaltrexone in the treatment of opioid-induced constipation.
|
Academic Article
|
Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
|
Academic Article
|
Carbostyril derivatives having potent beta-adrenergic agonist properties.
|
Academic Article
|
Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
|
Academic Article
|
Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
|
Academic Article
|
Synthesis and characterization of substituted benzoylhydrazones of naloxone.
|
Academic Article
|
GABA(A) receptor binding and localization in the tiger salamander retina.
|
Academic Article
|
Cellular G protein-coupled receptor kinase levels regulate sensitivity of the {alpha}2b-adrenergic receptor to undergo agonist-induced down-regulation.
|
Academic Article
|
Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
|
Academic Article
|
Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina.
|
Academic Article
|
Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells.
|
Academic Article
|
Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
|
Academic Article
|
Sigma binding in a human neuroblastoma cell line.
|
Academic Article
|
Characterizing kappa3 opioid receptors with a selective monoclonal antibody.
|
Academic Article
|
beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
|
Academic Article
|
Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats.
|
Academic Article
|
Synaptic protein expression by regenerating adult photoreceptors.
|
Academic Article
|
Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
|
Academic Article
|
Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
|
Academic Article
|
The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment.
|
Academic Article
|
Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment.
|
Academic Article
|
Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD.
|
Academic Article
|
Characterization of Tolerance in Children during Fentanyl Continuous Infusions.
|
Academic Article
|
Editorial: Current Topics in Opioid Research.
|
Academic Article
|
Modulation of mu 1, mu 2, and delta opioid binding by divalent cations.
|
Academic Article
|
Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations.
|
Academic Article
|
G proteins and opioid receptor-mediated signalling.
|
Academic Article
|
Understanding Opioid Actions, Pain and Analgesia: A Tribute to Dr. Gavril Pasternak.
|
Academic Article
|
Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) receptor modulators for treatment of traumatic brain injury, traumatic stress, and their co-morbidities.
|
Academic Article
|
TNF-Alpha as an Initiator of Allodynia and Anxiety-Like Behaviors in a Preclinical Model of PTSD and Comorbid Pain.
|
Academic Article
|
Recovery from traumatic brain injury (TBI) is Nociceptin/Orphanin FQ peptide (NOP) receptor genotype-, sex-, and injury severity-dependent.
|
Academic Article
|
The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury.
|
Academic Article
|
Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours.
|